The phosphatidylinositol-3-kinase (PI3K)/AKT signaling pathway regulates cell proliferation, survival, metabolism, EMT, and stem cell fate [25–27], and is aberrantly activated in 77% of breast cancers [9], including BRCA1-deficient disease [28]. This evidence concerns the gene BRCA1 and breast carcinoma.